Related Experiment Video
Updated: Jun 25, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
Decrease in adiponectin levels correlates to growth response in growth hormone-treated children
B Andersson1, L M S Carlsson, B Carlsson
1Department of Pediatrics, Goteborg Pediatric Growth Research Center, The Institute of Clinical Sciences, Göteborg, Sweden.
Insights
Growth hormone (GH) treatment in children lowers adiponectin levels, a hormone linked to obesity. This decrease in adiponectin correlates with improved growth response but not with insulin resistance.
Area of Science:
- Endocrinology
- Pediatrics
- Metabolic Research
Background:
- Adiponectin, a hormone secreted by adipose tissue, is crucial in metabolic regulation.
- Low adiponectin levels are associated with insulin resistance and obesity.
- Growth hormone (GH) plays a vital role in childhood growth and metabolism.
Purpose of the Study:
- To investigate the relationship between serum adiponectin levels and growth response during GH treatment in children.
- To examine potential correlations between adiponectin changes, insulin levels, and insulin resistance in this cohort.
Main Methods:
- A cohort of 94 short prepubertal children (75 boys, 19 girls) received daily GH injections.
- Serum adiponectin levels were quantified using ELISA at baseline and at multiple time points post-treatment.
- Statistical analyses, including correlation assessments, were performed to evaluate relationships between variables.
Main Results:
- Serum adiponectin levels significantly decreased from baseline after 1 week, 3 months, and 1 year of GH treatment (p < 0.0001).
- Baseline adiponectin showed a positive correlation with the first-year growth response (r = 0.26, p = 0.012).
- The magnitude of adiponectin decrease after 3 months and 1 year significantly correlated with the first-year growth response (r = -0.38 and r = -0.47, respectively; p < 0.0001).
Conclusions:
- Growth hormone treatment in prepubertal children leads to a significant reduction in serum adiponectin levels.
- The observed decrease in adiponectin is positively correlated with the treatment-induced growth response.
- No significant correlations were found between adiponectin levels and either insulin levels or insulin resistance (HOMA-IR) during GH therapy.
Background/Aims:
Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment.
Methods:
The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 +/- 2.38 years. Adiponectin levels in serum were measured using an ELISA.
Results:
At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 +/- 5.71 to 13.1 +/- 5.22 (p < 0.0001), 10.3 +/- 4.82 (p < 0.0001) and 12.5 +/- 5.34 microg/ml (p < 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = -0.38, p < 0.0001 and r = -0.47, p < 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen.
Conclusions:
GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.
Related Concept Videos
Signs of Puberty
Nature and Nurture
Regulation of Food Intake
Hypoglycemia and Glucagon
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
